Tag Archives: HEART

Amarin’s Vascepa nabs ADA backing to cut heart risks, even ahead of FDA review

The cardiovascular outcomes results Amarin rolled out for its fish oil-derived Vascepa may not have impressed all, but at least one leading health organization in the U.S. is ready to throw its weight behind the drug, even before an FDA review of the label expansion. The American Diabetes Association (ADA) on Wednesday said its 2019… Read More »